William Aird/X
Jul 15, 2025, 07:25
Rethinking Thrombocytosis: Dr. William Aird’s 3-Category Approach
Dr. William Aird, Professor of Medicine at Harvard Medical School, has posted on X:
“RETHINKING THROMBOCYTOSIS
Instead of just “primary” (clonal) vs “secondary” (reactive) consider 3 pathophysiologic buckets:
- Clonal (e.g., ET, PV)
- Reactive (inflammation, iron deficiency)
- Redistributional (asplenia)”

Find more on Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?